Yüklüyor......
Eslicarbazepine acetate add‐on therapy for drug‐resistant focal epilepsy
BACKGROUND: This is an update of a review first published in 2011, and last updated in 2017. Most people with epilepsy have a good prognosis, but up to 30% of people continue to have seizures despite several regimens of antiepileptic drugs. In this review, we summarized the current evidence regardin...
Kaydedildi:
| Yayımlandı: | Cochrane Database Syst Rev |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2021
|
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8218144/ https://ncbi.nlm.nih.gov/pubmed/34155624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008907.pub4 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|